Neubase Therapeutics shares owned by UBS Group
Quarter-by-quarter ownership of Neubase Therapeutics shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Neubase Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Neubase Therapeutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Neubase Therapeutics by UBS Group
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-03-31 | $1.8k | 4.1k | 0.45 |
2023-12-31 | $33k | 66k | 0.50 |
2023-06-30 | $126 | 68 | 1.87 |
Top funds holding Neubase Therapeutics
View all funds holding Neubase Therapeutics